Iridex Sees FY2026 Sales $51.000M-$53.000M vs $56.549M Est.
3/26/2026
Impact: -50
Healthcare
Iridex (NASDAQ: IRIX) has projected its FY2026 sales to be between $51.000 million and $53.000 million, which is below the analyst estimate of $56.549 million. This forecast indicates a potential shortfall in expected revenue for the company.
AI summary, not financial advice
Share: